Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 70 Pages
Report ld: 6306185
Request Sample
Customized Report
Fully MagLev Ventricular Assist Device (VAD) Market Size(US$)

CAGR 2026-2032
12.0%
Market Size,2032
USD 2,748
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Fully MagLev Ventricular Assist Device (VAD) market size was US$ 1256 million in 2025 and is forecast to reach a readjusted size of US$ 2748 million by 2032 with a CAGR of 12.0% during the forecast period 2026-2032.
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Currently, the global fully magnetic levitation ventricular assist device (VAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
From the perspective of the global VAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.
The global Fully MagLev Ventricular Assist Device (VAD) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Fully MagLev Ventricular Assist Device (VAD) sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Fully MagLev Ventricular Assist Device (VAD) manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Fully MagLev Ventricular Assist Device (VAD) product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Fully MagLev Ventricular Assist Device (VAD) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fully MagLev Ventricular Assist Device (VAD) Product Scope
1.2 Fully MagLev Ventricular Assist Device (VAD) by Type
1.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type (2021, 2025 & 2032)
1.2.2 Left Ventricular Assist Device (LVAD)
1.2.3 Biventricular Assist Device (BiVAD)
1.3 Fully MagLev Ventricular Assist Device (VAD) by Application
1.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Bridge-to-transplant (BTT)
1.3.3 Destination Therapy (DT)
1.3.4 Others
1.4 Global Fully MagLev Ventricular Assist Device (VAD) Market Estimates and Forecasts (2021-2032)
1.4.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Fully MagLev Ventricular Assist Device (VAD) Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Fully MagLev Ventricular Assist Device (VAD) Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Fully MagLev Ventricular Assist Device (VAD) Historical Market Scenario by Region (2021-2026)
2.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Region (2021-2026)
2.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Region (2021-2026)
2.3 Global Fully MagLev Ventricular Assist Device (VAD) Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Fully MagLev Ventricular Assist Device (VAD) Market Size and Prospects (2021-2032)
2.4.2 China Fully MagLev Ventricular Assist Device (VAD) Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Fully MagLev Ventricular Assist Device (VAD) Historical Market Review by Type (2021-2026)
3.1.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type (2021-2026)
3.1.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Type (2021-2026)
3.1.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Type (2021-2026)
3.2 Global Fully MagLev Ventricular Assist Device (VAD) Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Type (2027-2032)
3.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Forecast by Type (2027-2032)
3.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Fully MagLev Ventricular Assist Device (VAD)
4 Global Market Size by Application
4.1 Global Fully MagLev Ventricular Assist Device (VAD) Historical Market Review by Application (2021-2026)
4.1.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application (2021-2026)
4.1.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application (2021-2026)
4.1.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Application (2021-2026)
4.2 Global Fully MagLev Ventricular Assist Device (VAD) Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Application (2027-2032)
4.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Forecast by Application (2027-2032)
4.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Fully MagLev Ventricular Assist Device (VAD) Applications
5 Competition Landscape by Players
5.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Player (2021-2026)
5.2 Global Top Fully MagLev Ventricular Assist Device (VAD) Players by Revenue (2021-2026)
5.3 Global Fully MagLev Ventricular Assist Device (VAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Fully MagLev Ventricular Assist Device (VAD) revenue as of 2025
5.4 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Fully MagLev Ventricular Assist Device (VAD), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Fully MagLev Ventricular Assist Device (VAD), Product Type & Application
5.7 Global Key Manufacturers of Fully MagLev Ventricular Assist Device (VAD), Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales by Company
6.1.1.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales by Company (2021-2026)
6.1.1.2 North America Fully MagLev Ventricular Assist Device (VAD) Revenue by Company (2021-2026)
6.1.2 North America Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
6.1.3 North America Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
6.1.4 North America Fully MagLev Ventricular Assist Device (VAD) Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 China Market: Players, Segments, Downstream and Major Customers
6.2.1 China Fully MagLev Ventricular Assist Device (VAD) Sales by Company
6.2.1.1 China Fully MagLev Ventricular Assist Device (VAD) Sales by Company (2021-2026)
6.2.1.2 China Fully MagLev Ventricular Assist Device (VAD) Revenue by Company (2021-2026)
6.2.2 China Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
6.2.3 China Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
6.2.4 China Fully MagLev Ventricular Assist Device (VAD) Major Customers
6.2.5 China Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Business Overview
7.1.3 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Abbott Fully MagLev Ventricular Assist Device (VAD) Products Offered
7.1.5 Abbott Recent Development
7.2 BiVACOR
7.2.1 BiVACOR Company Information
7.2.2 BiVACOR Business Overview
7.2.3 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
7.2.4 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Products Offered
7.2.5 BiVACOR Recent Development
7.3 Suzhou Tongxin Medical Devices
7.3.1 Suzhou Tongxin Medical Devices Company Information
7.3.2 Suzhou Tongxin Medical Devices Business Overview
7.3.3 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Products Offered
7.3.5 Suzhou Tongxin Medical Devices Recent Development
7.4 Shenzhen Core Medical Technology
7.4.1 Shenzhen Core Medical Technology Company Information
7.4.2 Shenzhen Core Medical Technology Business Overview
7.4.3 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Products Offered
7.4.5 Shenzhen Core Medical Technology Recent Development
8 Fully MagLev Ventricular Assist Device (VAD) Manufacturing Cost Analysis
8.1 Fully MagLev Ventricular Assist Device (VAD) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Fully MagLev Ventricular Assist Device (VAD)
8.4 Fully MagLev Ventricular Assist Device (VAD) Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Fully MagLev Ventricular Assist Device (VAD) Distributors List
9.3 Fully MagLev Ventricular Assist Device (VAD) Customers
10 Fully MagLev Ventricular Assist Device (VAD) Market Dynamics
10.1 Fully MagLev Ventricular Assist Device (VAD) Industry Trends
10.2 Fully MagLev Ventricular Assist Device (VAD) Market Drivers
10.3 Fully MagLev Ventricular Assist Device (VAD) Market Challenges
10.4 Fully MagLev Ventricular Assist Device (VAD) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fully MagLev Ventricular Assist Device (VAD) market is projected to grow from US$ 1256 million in 2025 to US$ 2748 million by 2032, at a CAGR of 12.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 122
USD 4900.00
(Single User License)
The global market for Fully MagLev Ventricular Assist Device (VAD) was estimated to be worth US$ 1256 million in 2025 and is projected to reach US$ 2748 million, growing at a CAGR of 12.0% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 89
USD 3950.00
(Single User License)
The global Fully MagLev Ventricular Assist Device (VAD) market was valued at US$ 1256 million in 2025 and is anticipated to reach US$ 2748 million by 2032, at a CAGR of 12.0% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 96
USD 2900.00
(Single User License)
The global Fully MagLev Ventricular Assist Device (VAD) market is projected to grow from US$ 1134 million in 2024 to US$ 2480 million by 2031, at a CAGR of 12.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 127
USD 4900.00
(Single User License)
The global Fully MagLev Ventricular Assist Device (VAD) market size was US$ 1134 million in 2024 and is forecast to a readjusted size of US$ 2480 million by 2031 with a CAGR of 12.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 71
USD 4250.00
(Single User License)
The global market for Fully MagLev Ventricular Assist Device (VAD) was estimated to be worth US$ 1134 million in 2024 and is forecast to a readjusted size of US$ 2480 million by 2031 with a CAGR of 12.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 80
USD 3950.00
(Single User License)
The global market for Fully MagLev Ventricular Assist Device (VAD) was valued at US$ 1134 million in the year 2024 and is projected to reach a revised size of US$ 2480 million by 2031, growing at a CAGR of 12.0% during the forecast period.
Published Date: 2025-03-10
Pages: 68
USD 2900.00
(Single User License)
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Published Date: 2024-09-15
Pages: 80
USD 4350.00
(Single User License)
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Published Date: 2024-09-15
Pages: 68
USD 2900.00
(Single User License)
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Published Date: 2024-09-15
Pages: 108
USD 4900.00
(Single User License)
The global Fully MagLev Ventricular Assist Device (VAD) market is projected to grow from US$ 1256 million in 2025 to US$ 2748 million by 2032, at a CAGR of 12.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 122
The global market for Fully MagLev Ventricular Assist Device (VAD) was estimated to be worth US$ 1256 million in 2025 and is projected to reach US$ 2748 million, growing at a CAGR of 12.0% from 2026 to 2032.
Published: 2026-01-09
Pages: 89
The global Fully MagLev Ventricular Assist Device (VAD) market was valued at US$ 1256 million in 2025 and is anticipated to reach US$ 2748 million by 2032, at a CAGR of 12.0% from 2026 to 2032.
Published: 2026-01-09
Pages: 96
The global Fully MagLev Ventricular Assist Device (VAD) market is projected to grow from US$ 1134 million in 2024 to US$ 2480 million by 2031, at a CAGR of 12.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 127
The global Fully MagLev Ventricular Assist Device (VAD) market size was US$ 1134 million in 2024 and is forecast to a readjusted size of US$ 2480 million by 2031 with a CAGR of 12.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 71
The global market for Fully MagLev Ventricular Assist Device (VAD) was estimated to be worth US$ 1134 million in 2024 and is forecast to a readjusted size of US$ 2480 million by 2031 with a CAGR of 12.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 80
The global market for Fully MagLev Ventricular Assist Device (VAD) was valued at US$ 1134 million in the year 2024 and is projected to reach a revised size of US$ 2480 million by 2031, growing at a CAGR of 12.0% during the forecast period.
Published: 2025-03-10
Pages: 68
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Published: 2024-09-15
Pages: 80
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Published: 2024-09-15
Pages: 68
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Published: 2024-09-15
Pages: 108
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now